Superscript, a London, UK-based insurtech startup that provides insurance platforms to SMEs, raised £45 million ($54 million) in Series B funding. BHL UK, the owner of Comparethemarket, led the round, with participation from a new investor, The Hartford, and existing investors, including Concentric. The funds will be used to further …
Arctic Shores, a Manchester, UK-based psychometric assessment provider, secured £5.75 million in Series B funding. The round was led by Praetura Ventures and Calculus Capital, with participation from existing shareholder Beringea. The funds will be used to accelerate the development of its soft-skills assessment and international expansion, specifically in Europe, …
AutoRABIT, a San Francisco, CA-based DevSecOps platform for optimized and streamlined salesforce application development, secured a $26 million Series B funding round from Full In Partners. It furthered its expansion by opening a new office in Prague to act as the company's international headquarters. "We're very excited to be able …
Nanoprecise, an Edmonton, Canada-based company that provides AI-based condition monitoring and prescriptive maintenance solutions, raised $10 million in Series B funding. The round was led by Export Development Canada (EDC), with participation from Honeywell Ventures, NSK Ltd., and EC Mergers & Acquisitions. This funding aims to boost the Canadian cleantech …
Ganymed Robotics, a Paris, France-based developer of computer vision software and robotics technologies for orthopedic surgeons, announced it has extended its Series B with an additional €15 million, bringing the total Series B amount to €36 million. The Fund of the European Innovation Council, through its Accelerator Program, and Cap …
Volta Medical, a Marseille, France-based health technology company that leverages artificial intelligence to revolutionize interventional cardiac electrophysiology, announced that it raised €36 million in Series B funding, bringing its total raised to more than €70 million. The round was led by U.S.-based Vensana Capital, with participation from Lightstone Ventures and …
Enveda Biosciences, a Boulder, CO-based biotechnology company, announced that it closed a $68 million in Series B equity and debt financing, bringing its total raised to $124 million. The round was led by Dimension, which included participation by multiple new institutional investors, including FPV, Jazz Venture Partners, Level Ventures, Amino …
